In VitroPhase II Comparison of the Cytotoxicity of a Novel Platinum Analog, Nedaplatin (254-S), with That of Cisplatin and Carboplatin against Fresh, Human Cervical Cancers

By Monk B.J.   Alberts D.S.   Burger R.A.   Fanta P.T.   Hallum A.V.   Hatch K.D.   Salmon S.E.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 308-312

Elsevier

Access to resources Recommend Favorite

The combination of yondelis and cisplatin is synergistic against human tumor xenografts

By D'Incalci M.   Colombo T.   Ubezio P.   Nicoletti I.   Giavazzi R.   Erba E.   Ferrarese L.   Meco D.   Riccardi R.   Sessa C.   Cavallini E.   Jimeno J.   Faircloth G.T.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1920-1926

Elsevier

Access to resources Recommend Favorite

Radiation Biology of Human Tumour Xenografts

By Rofstad Einar K.  

International Journal of Radiation Biology, Vol. 56, Iss. 5, 1989-11 ,pp. : 573-581

Informa Healthcare

Access to resources Recommend Favorite

Cycloplatam: A Novel Platinum Compound Exhibiting a Different Spectrum of Anti-tumour Activity to Cisplatin

By Drees M.   Dengler W.M.   Hendriks H.R.   Kelland L.R.   Fiebig H.H.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 356-361

Elsevier

Access to resources Recommend Favorite

Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts

By Langdon S.P.   Ritchie A.A.   Muir M.   Dodds M.   Howie A.F.   Leonard R.C.F.   Stockman P.K.   Miller W.R.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 384-388

Elsevier

Access to resources Recommend Favorite